Revenue YoY
+1.78%
Operating Income YoY
+13.93%
Net Income YoY
+34.20%
Net Margin Δ
+362 bps
Net income bridge for Bristol-Myers Squibb (BMY) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: $1.86B+34.20%
Profit bridge breakdown for Bristol-Myers Squibb (BMY) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | $5.42B | — |
| Revenue | $846.00M | +45.6% |
| Cost of Revenue | $4.30B | +231.8% |
| Operating Expenses | −$3.63B | -195.4% |
| Other Income / Expense | $1.97B | +106.0% |
| Income Tax | −$1.65B | -89.1% |
| Other Items | $20.00M | +1.1% |
| Net Income | $7.28B | — |
- Prior Net Income$5.42B
- Revenue$846.00M
- Cost of Revenue$4.30B
- Operating Expenses−$3.63B
- Other Income / Expense$1.97B
- Income Tax−$1.65B
- Other Items$20.00M
- Net Income$7.28B
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
Bristol-Myers Squibb (BMY) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement